Compare MCK and ELV

compare mck to elv

{"response_type": "stock_research", "acknowledgement": "Here's a comparison between McKesson Corporation (MCK) and Elevance Health, Inc. (ELV).", "answer": "**McKesson Corporation (MCK)** and **Elevance Health, Inc. (ELV)** are both in the Healthcare sector but exhibit notable differences:\n\n- **Market Cap:** MCK $88.3B vs ELV $82.1B\n- **Revenue:** MCK $403.4B vs ELV $200.4B\n- **Net Income:** MCK $4.76B vs ELV $5.24B\n- **Trailing P/E:** MCK 19.19 vs ELV 16.03\n- **Forward P/E:** MCK 14.66 vs ELV 12.94\n- **Price-to-Book Ratio:** MCK -40.67 (likely due to accounting adjustments) vs ELV 1.87\n- **Price-to-Sales Ratio:** MCK 0.22 vs ELV 0.41\n- **EV/EBITDA:** MCK 13.68 vs ELV 9.02\n- **Dividend Yield:** MCK 0.45% vs ELV 1.82%\n- **Beta (volatility):** MCK 0.36 vs ELV 0.67\n\n**Performance over the latest session:**\n- MCK gained +6.57%\n- ELV lost -4.56%\n\nMCK shows a larger scale in revenue with moderate earnings and a higher valuation multiple despite lower dividend yield and volatility. ELV has smaller revenue but higher net income and dividend yield, with better valuation ratios and more volatility.\n", "interpretation": "MCK's stronger revenue base and recent positive returns suggest resilience, while ELV's lower valuation multiples and higher dividend make it attractive for yield-focused investors despite recent negative total return. Consider sector exposure, risk tolerance, and dividend preference when comparing these peers.", "hypothesis": {"text": "MCK's larger scale and recent positive returns suggest operational stability, while ELV's valuation suggests possible undervaluation or market concerns.", "confidence": "Moderate"}, "insights": ["MCK's 1-year total return outperformed ELV by over 10 percentage points.", "ELV offers a substantially higher dividend yield but with higher stock volatility."], "suggested_questions": ["Check MCK earnings history and forward estimates", "Compare ELV dividend sustainability", "Analyze Healthcare sector trends"], "charts": [{"type": "bar", "title": "Key Financial Metrics for MCK and ELV", "data": [{"label": "Market Cap ($B) - MCK", "value": 88.33}, {"label": "Market Cap ($B) - ELV", "value": 82.1}, {"label": "Revenue ($B) - MCK", "value": 403.43}, {"label": "Revenue ($B) - ELV", "value": 200.42}, {"label": "Net Income ($B) - MCK", "value": 4.76}, {"label": "Net Income ($B) - ELV", "value": 5.24}, {"label": "Trailing P/E - MCK", "value": 19.19}, {"label": "Trailing P/E - ELV", "value": 16.03}, {"label": "Forward P/E - MCK", "value": 14.67}, {"label": "Forward P/E - ELV", "value": 12.94}, {"label": "Dividend Yield (%) - MCK", "value": 0.45}, {"label": "Dividend Yield (%) - ELV", "value": 1.82}]}, {"type": "bar", "title": "1-Year Total Return (%)", "data": [{"label": "MCK", "value": 6.57}, {"label": "ELV", "value": -4.56}]}], "actions": [{"label": "Deep dive into MCK", "action_type": "analyze_stock", "parameters": {"ticker": "MCK"}}, {"label": "Deep dive into ELV", "action_type": "analyze_stock", "parameters": {"ticker": "ELV"}}, {"label": "View Healthcare sector", "action_type": "view_sector", "parameters": {"sector": "Healthcare"}}], "supporting_data": [], "risk_watch": "", "structured_data": {"template": "stock_comparison", "stocks": {"MCK": {"name": "McKesson Corporation", "sector": "Healthcare", "market_cap": 88330805248, "revenue": 403430014976, "net_income": 4761999872, "pe_trailing": 19.194004, "pe_forward": 14.665699, "pb_ratio": -40.667957, "ps_ratio": 0.21894951, "ev_to_ebitda": 13.684, "dividend_yield": 0.45, "beta": 0.355}, "ELV": {"name": "Elevance Health, Inc.", "sector": "Healthcare", "market_cap": 82102583296, "revenue": 200416002048, "net_income": 5242999808, "pe_trailing": 16.026707, "pe_forward": 12.936629, "pb_ratio": 1.8719116, "ps_ratio": 0.40966082, "ev_to_ebitda": 9.017, "dividend_yield": 1.82, "beta": 0.671}}, "returns": {"MCK": {"total_return_pct": 6.57, "start_price": 690.73, "end_price": 736.09}, "ELV": {"total_return_pct": -4.56, "start_price": 396.12, "end_price": 378.07}}}}